European Pharma Days 2022

Bruker's and M2Aind's 3rd Mass Spectrometry Innovations in Pharma Meeting

Join several industry leaders from top pharma around the globe as they present their perspectives on advanced MS based technologies like trapped ion mobility and MALDI Imaging and how these new technologies are transforming drug discovery.

When? Wednesday, April 27th and Thursday, 28th 2022 

Where? Hochschule Mannheim, Aula, Paul-Wittsack-Strasse 10, 68163 Mannheim, Germany

This 2-day event will cover applications within:

 

Seminar Sessions

Day 1: April 27, 2022, 10:00 am – 19:00 pm: Biologics Characterization

Prof. Dr. Matthias Mann, Director, Department of Proteomics and Signal Transduction, Max-Planck-Institute of Biochemistry, Martinsried, German

Day 2: April 28, 2022, 9:00 am – 17:00 pm: MALDI Imaging

Dr. Peter Marshal, Principal Research Analyst, GlaxoSmithKline, Stevenage, United Kingdom 

 

The event is held in a safe, comfortable environment where you can meet and learn from the leading scientist in the pharmaceutical industry and academia. Organized by  Bruker, M2Aind and CeMOS – Center for Mass Spectrometry and Optical Spectroscopy. 

Reserve your free seat by clicking the registration link below.

REGISTER HERE

Please click here for more information.

M2Aind-Talk-Live meets MEDTECHON-SITE

Online-EVENT

When: 25.6.2020, 12 p.m. to 2.30 p.m.

Part 1

M2Aind TalkLive

Topic: "Measurement technology horizons for medicine and chemistry"

Exciting live webinars:

1. Julian Deuerling, CeMOS, Mannheim University of Applied Sciences

Measurement technology horizons in the chemical-pharmaceutical industry and measurement technology

2. Dr. Jens Nolte Eckhardt, Tec5 AG

Requirements for and solution approaches with spectroscopic in-line process sensors for Industry 4.0: Applications in the chemical and pharmaceutical industry

3. Dr. Jochen Friedemann und Daniel Schock-Kusch, MediBeacon GmbH

Fluorescent organ function markers: Minimally invasive measurement of important vital functions and clinical parameters

Part 2

Live-Stream der Stadt Mannheim "MEDTECHON-SITE"

MEDTECHON-SITE  Live from the Bruker Rhine-Neckar Center in the CeMOS research center. During a tour of the Bruker Center, the city of Mannheim will provide information about the possibilities of cooperation between the Mannheim University of Applied Sciences and companies and will present some industrial projects of the M²Aind innovation partnership. Moderation: Dr. Elmar Bourdon, City of Mannheim

Please register at: medtech@mannheim.de  to the events. When registering, please indicate whether you would like to attend both or which of the events you would like to attend.

Click here for the program

 

Bioanalytics of Biopharmaceuticals (BOB)

Biannual exchange of experiences with short talks

When: Tuesday, 5.11.2019, 3pm to 5:25 p.m. (till 7 for hard networkers)
Where: Mannheim University of Applied Sciences, Karl-Völker-Saal, 4th floor, building A, Speyerer Straße 2-4, 68163 Mannheim


Tuesday, November 5, 2019 and come to our biannual exchange of Solutions for Challenges in Bioanalytics of Biopharmaceuticals incl. short impulse talks.
     
We are very happy to welcome the following speakers of the health industry at our event:

1. Dr. Soraya Hölper, Sanofi, Frankfurt
2. Dr. Thomas Schirrmann, CEO, Yumab GmbH, Braunschweig
3. Prof. Dr. Peter Findeisen, MVZ Labor Dr. Limbach & Kollegen, Heidelberg
4. Dr. Christian Albers (requested), Bruker Daltonik GmbH, Bremen

 

If you would like to register immediately, please send us an e-mail: m2aind@hs-mannheim.de

More information will follow shortly.

Smart Drug Development & Design from Candidate to Phase I

When: April 4 I 9:30am – 2:15pm
Where: Conference Center Technology Park, Im Neuenheimer Feld 582, Heidelberg

This event will focus on key considerations for transitioning a molecule from discovery to phase 1 readiness including API and formulation development, pharmacokinetics, quality and CMC requirements, and incorporation of clinical supply services solutions to meet protocol, clinical site and patient needs.

Here you will find the Programm. More information will be available here.

Please register for the free Seminar here.

Following the meeting, all Catalent speakers and executives will be available for private, no-obligation discussions on specific programmes and challenges. To request an appointment, please contact Annalisa Zuccotti (az@biorn.org).

Note: M²Aind is not involved in this event. This is an announcement of the event.

Bioanalytics of Biopharmaceuticals (BOB)

Biannual exchange of experiences with short talks

When: Tuesday, 2.4.2019, 3pm to 6pm
Where: Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt

In person and on behalf of our co-organizer Merck KGaA, we cordially invite you to our second event biannual Exchange of Solutions for Challenges in Bioanalytics of Biopharmaceuticals with Keynote Speeches in the Bioanalytics of Biopharmaceuticals Division.

We present you

Short talks

  • Dr. Friedrich Reinhard, Cellzome, a GSK Company - Chemoproteomics and Thermal Protein Profiling in Target Discovery and Validation
  • Dr. Christian Lutz, Heidelberg Pharma Research GmbH - Analytical characterization of antibody-amatoxin conjugates (ADCs)
  • Dr. Sibylle Heidelberger, AB Sciex Germany GmbH - Development of High Throughput Online Native LC/MS

Please register until March 18th, 2019 at the following e-mail address: m2aind@hs-mannheim.de. Further details will be provided after your registration. We would be very pleased about your participation.

Mass Spectrometry and Surface Plasmon Resonance (SPR) Innovations in Pharma

Join several industry leaders from top pharma companies and academia around the globe as they present their  perspectives on using advanced MS and SPR based  technologies to streamline the drug development process. From lead generation all  the way through to pre-clinical assessment, Bruker has built on years of excellence in Mass Spectrometry to impact the pharmacological  related industry far beyond the traditional role of quantitation and process monitoring.

Seminar sessions
March 18, 2019 // 9.30 am - 6.30 pm
rapifleX MALDI Pharma Pulse, timsTOF Pro (trapped ion mobility) and SPR-32 (surface plasmon resonance) applications in Pharma
March 19, 2019 // 9 am - 4 pm
MS Imaging Applications in Pharma

Get more information here.

5th M²Aind Talk on Tuesday, February 19, 2019 from 4:00 p.m. to 7:00 p.m.

We are pleased that the M²Aind Talk is taking place outside the home for the first time and that we will be guests at the IHK Rhein-Neckar in Heidelberg. We would like to thank the IHK Rhein-Neckar for their support and hospitality. At this M²Aind Talk, the three keynote speeches - based on the SM²all impulse project - deal with the subject of chemical analysis with ion mobility spectrometry and drug testing in assays.
 

Program:

4 p.m. reception

4.30 p.m. welcome

4.40 p.m. Lectures:

GC-IMS – Selective trace gas analysis of volatile compounds in industrial applications
Thomas Wortelmann, G.A.S. Gesellschaft für analytische Sensorsysteme mbH
Approaches to the quantification of terpenes from complex mixtures using two-dimensional GC-IMS und MCR-ALS
Prof. Dr. Philipp Weller / Rebecca Brendel, Innovationspartnerschaft M²Aind
Discovery of potent inhibitors of the hepatic & intestinal drug transporter OATP2B1 through a cell based fluorescence assay
Melissa Unger, Innovationspartnerschaft M²Aind, Mannheim University of Applied Sciences

17.30 Uhr            Networking with finger food and drinks
Ca. 19.00 Uhr     End of the event

Please register by February 10, 2019 at the following email address: m2aind@hs-mannheim.de
 
Address:
IHK Rhein-Neckar
Theodor Frey Saal
Hans-Böckler-Straße 4
69115 Heidelberg

Please note that the IHK Rhein-Neckar does not offer any parking facilities. However, there are numerous parking garages nearby. The IHK Rhein-Neckar can also be easily reached by public transport. You will find a map of how to get there here

Park:
Parking garage Poststraße, Poststraße 7-9, 69115 Heidelberg
Parking garage Bauhaus, Bahnhofstraße 4, 69115 Heidelberg
Parking garage Europäischer Hof, Friedrich-Ebert-Anlage 1, 69117 Heidelberg

Arrival by public transport: You can reach us by all means of public transport: Bismarckplatz stop

Bioanalytics of Biopharmaceuticals (BOB)

Biannual exchange of experiences with short talks

When: Tuesday, 9.10.2018, 4pm to 7pm
Where: Mannheim University of Applied Sciences, Karl-Völker-Saal, 4th floor, building A, Speyerer Straße 2-4, 68163 Mannheim

  • 4:00 pm - Networking with coffee and cake
  • 4:30 pm - Welcome and introduction to the topic Bioanalytics of Biopharmaceuticals and Introduction M²Aind, Dr. Roland Kellner Merck KGaA, Darmstadt and Prof. Dr. Carsten Hopf, Center forMass Spectrometry and Optical Spectroscopy (CEMOS)
  • 4:45 pm - ADCs: Searching for the magic bullet | Dr. Jan Anderl, Merck KGaA, Darmstadt
  • 5:10 pm - Developing First-In-Class Immune Cell Engagers for the Activation of Innate and Adaptive Immunity to Fight Cancer, Thomas Müller, Affimed GmbH, Heidelberg
  • 5:35 pm- LC-MALDI analysis of biopharmaceuticals: A real strange idea or a solution to current issues with potential? Dr. Detlev Suckau, Bruker Daltonik GmbH, Bremen
  • 5:50 pm - Networking with food and drinks

Please register atm2aind@hs-mannheim.de

2. M²Aind Talk

On April 17, 2018, the M²Aind innovation partnership organized the 2nd M²Aind Talk. This is a get-together for the health industry for the greater Rhine-Main-Neckar area.

There were three keynote speeches on the subject of "Process Development and Process Analytics":

  • Intro: Herr Dr. Siegfried Bialojan, Ernst & Young GmbH
  • Herr Stefan Bley, Ernst & Young GmbH, Industry 4.0 – Smart Production
  • Herr Prof. Dr. Thorsten Röder, Mannheim University of Applied Sciences, Multiphase reaction in microreactors
  • Herr Thomas Müller und Herr Ralf Stegemann, EM-Technik GmbH, Innovation in plastic

We would like to thank the E&Y Wirtschaftsprüfungsgesellschaft for their kind support.

MALDI Innovations in Pharma Feb 21 & 22, 2018

Bruker Daltonics and the M2Aind Partnership for Innovation in Health Industry are organizing a two-day workshop on “MALDI Innovations in Pharma”, which shall take place on Feb 21st/22nd in Mannheim.
The first day will focus onrapifleX PharmaPulse – MALDI MS-based assays for compound profiling incl HTS. Day 2 will feature current applications in pharma industry and in chemical biology.

Please, register via the Bruker website.

Seminar Sessions

February 21: rapifleX MALDI PharmaPulse: reset your expectation for label-free high-throughput-screening utilizing mass spectrometry

February 22: MS Imaging Applications in Pharma and Chemical Biology

1. M²Aind Talk

Your meeting point for the healthcare industry in the greater Rhine-Neckar-Main area

The M²Aind Talk is a get-together of the health industry for the greater Rhine-Neckar-Main area. Representatives of the regional health industry use the opportunity to exchange ideas and learn new things from the industry.

Where: Karl Völker Saal, Building A, Mannheim University of Applied Sciences

When: November 20, 2017 from 4 p.m. to 7 p.m.

Exciting keynote speeches await you:
- Prof. Dr. Marcus Rieker - Horiba Europe GmbH
- Prof. Dr. Matthias Rädle, M2Aind - Mannheim University of Applied Sciences
- Prof. Dr. Carsten Hopf, M2Aind - Mannheim University of Applied Sciences

Program items

4:00 p.m. reception and start

4.30 p.m. Welcome and short talks

5.30 p.m. Networking

Please register at the following email address: m2aind@hs-mannheim.de

BIORN ANNUAL CONFERENCE 2017

REVOLUTION THROUGH CONVOLUTION – COMBINING MEDTECH, BIOTECH AND DIGITAL HEALTH TO PROMOTE HEALTH SCIENCE IN OUR REGION

This year's BioRN annual conference on October 24th, 2017, once again offers a varied program and numerous networking opportunities. In addition to specialist presentations on the conference topic, BioRN members have the opportunity to present their project or company in short presentations. The program is rounded off by a poster exhibition.

The previously confirmed speakers are:

    Clemens Suter-Crazzolara (SAP)

    Elmar Bourdon (Medtech Cluster Mannheim)

    Nico Stam (Health Axis Europe Partner, Brightlands Maastricht Health Campus)

    Gitte Neubauer (Cellzome, a GSK company)

    Andrée Rothermel (Ci3)

    Kai Gräber (Ci3)

    Wulf Fischer-Knuppertz (BIOCRATES Life Sciences AG)

    Prof. Carsten Hopf (Hochschule Mannheim)

    Prof. Rüdiger Rudolf  (Hochschule Mannheim)

You can find more information about the event here.

Events of our partners with M²Aind

Mannheim University of Applied Sciences

M²Aind project coordination
Paul-Wittsack-Strasse 10
68163 Mannheim

+49 621 292-6579
m2aind@hs-mannheim.de

Follow us on LinkedIn and YouTube!